Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Development of the Bispecific Outpatient Readiness Score (BORS): An Institutional Readiness Tool for Outpatient Bispecific Antibody Therapy in Multiple Myeloma

MM - 995

Development of the Bispecific Outpatient Readiness Score (BORS): An Institutional Readiness Tool for Outpatient Bispecific Antibody Therapy in Multiple Myeloma

Nanditha Karra

Poster Presenter: Nanditha Karra

Thumbnail for Genetic Heterogeneity and Alternative Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

CML - 996

Genetic Heterogeneity and Alternative Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Daria Kustova

Poster Presenter: Daria Kustova

Previous 1...79 80 81 82 83 84 85...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Evolving Trends in Cardiac Arrest-Associated Mortality Among Patients With Non-Hodgkin Lymphoma in the United States: A CDC WONDER Population-Based Study (1999-2025)

HL - 997

Evolving Trends in Cardiac Arrest-Associated Mortality Among Patients With Non-Hodgkin Lymphoma in the United States: A CDC WONDER Population-Based Study (1999-2025)

Muhammad Jawad

Poster Presenter: Muhammad Jawad

Thumbnail for Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

AML - 998

Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study

Milvyd? Tamutyt?-Jankausk?

Poster Presenter: Milvyd? Tamutyt?-Jankausk?

Thumbnail for Therapeutic Strategies After CAR-T Failure in B-Cell Malignancies: A Systematic Review and Network Meta-Analysis

IBCL - 1000

Therapeutic Strategies After CAR-T Failure in B-Cell Malignancies: A Systematic Review and Network Meta-Analysis

Shrunga Kandhi Raghavendra

Poster Presenter: Shrunga Kandhi Raghavendra

$Thumbnail for Cellular Kinetics, Efficacy, and Safety of Zamtocabtagene Autoleucel, a Tandem CD20/CD19-Directed CAR T-Cell Therapy, vs R-GemOx in Patients With Relapsed/Refractory LBCL (DALY 2-EU Study)$

ABCL - 1001

Cellular Kinetics, Efficacy, and Safety of Zamtocabtagene Autoleucel, a Tandem CD20/CD19-Directed CAR T-Cell Therapy, vs R-GemOx in Patients With Relapsed/Refractory LBCL (DALY 2-EU Study)

Nirav Shah

Poster Presenter: Nirav Shah

Thumbnail for Clinical Presentation and Treatment Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Experience

CT - 1002

Clinical Presentation and Treatment Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Real-World Experience

Alishba Farooq Khawaja

Poster Presenter: Alishba Farooq Khawaja

Thumbnail for Antibiotic Escalation and Early Infectious Complications Following Antithymocyte Globulin (ATG) and Posttransplant Cyclophosphamide (PTCy)-Based Haploidentical Stem Cell Transplantation

CT - 1003

Antibiotic Escalation and Early Infectious Complications Following Antithymocyte Globulin (ATG) and Posttransplant Cyclophosphamide (PTCy)-Based Haploidentical Stem Cell Transplantation

Sally Chahine

Poster Presenter: Sally Chahine

$Thumbnail for Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety$

ABCL - 1004

Long-Term Outcomes of Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: A Systematic Review of Efficacy, Survival, Minimal Residual Disease, and Safety

Sai Harsha Yendluri

Poster Presenter: Sai Harsha Yendluri

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors